Page last updated: 2024-09-04

lonafarnib and pd 184352

lonafarnib has been researched along with pd 184352 in 1 studies

Compound Research Comparison

Studies
(lonafarnib)
Trials
(lonafarnib)
Recent Studies (post-2010)
(lonafarnib)
Studies
(pd 184352)
Trials
(pd 184352)
Recent Studies (post-2010) (pd 184352)
2243490185374

Protein Interaction Comparison

ProteinTaxonomylonafarnib (IC50)pd 184352 (IC50)
RAF proto-oncogene serine/threonine-protein kinaseHomo sapiens (human)0.012
Dual specificity mitogen-activated protein kinase kinase 2Homo sapiens (human)0.0263
Casein kinase II subunit alphaHomo sapiens (human)0.017
Dual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)0.0218

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dancey, JE1

Reviews

1 review(s) available for lonafarnib and pd 184352

ArticleYear
Agents targeting ras signaling pathway.
    Current pharmaceutical design, 2002, Volume: 8, Issue:25

    Topics: Alkyl and Aryl Transferases; Animals; Antineoplastic Agents; Benzamides; Benzodiazepines; Enzyme Inhibitors; Farnesyltranstransferase; Gene Expression Regulation, Neoplastic; Genes, ras; Humans; Imidazoles; MAP Kinase Kinase Kinases; Oligonucleotides, Antisense; Phosphorothioate Oligonucleotides; Piperidines; Proto-Oncogene Proteins c-raf; Pyridines; Quinolones; Signal Transduction

2002